📖

In Alzheimer's disease, biomarker events occur in a specific temporal sequence: amyloid-β abnormalit

superseded

wiki page Created: 2026-04-03T05:04:50 By: crosslink-expanded Quality: 50% ✓ SciDEX ID: wiki-hypotheses-alzheimers-disease-bioma

📅 Version Timeline 2 versions

v1 ●

2026-04-03T05:04:50

2026-04-12T12:30:35

Merged from 2 duplicates (dedup recommendation #8)

hypotheses-alzheimers-disease-biomarker-events-occur

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

Debates

Incoming

Outgoing

113

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (113)

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade55%

mentions🧪Prefrontal sensory gating circuit restoration via PV interne55%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization55%

mentions🧪Ocular Immune Privilege Extension55%

mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation55%

mentions🧪Orexin-Microglia Modulation Therapy55%

mentions🧪Lysosomal Calcium Channel Modulation Therapy55%

mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)55%

mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement55%

mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi55%

mentions🧪Netrin-1 Gradient Restoration55%

mentions🧪Digital Twin-Guided Metabolic Reprogramming55%

mentions🧪Ganglioside Rebalancing Therapy55%

mentions🧪Multi-Modal Stress Response Harmonization55%

mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati55%

mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics55%

mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In55%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones55%

mentions🧪Nucleolar Stress Response Normalization55%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy55%

mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 55%

mentions🧪Lipid Droplet Dynamics as Phenotype Switches55%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation55%

mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation55%

mentions🧪Mitochondrial RNA Granule Rescue Pathway55%

mentions🧪APOE-TREM2 Interaction Modulation50%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and50%

related🧫Sex Differences in Alzheimer's Disease — mechanisms and50%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%

related🧫Autophagy Enhancement Drug Screening for Neurodegeneration50%

related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#50%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%

related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol50%

related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise50%

related🧫4R-Tau Targeting Therapies for PSP and CBS50%

related🧫Prion Strain Diversity and Selective Vulnerability50%

related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr50%

related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech50%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 50%

related🧫s:** - Test whether HCN1 knockout specifically in EC layer I50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

related🧫Animal Model Comparison for Neurodegenerative Disease Therap50%

related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera50%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪APOE Isoform Conversion Therapy50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

related🧫ApoE4 Function in Alzheimer's Disease50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

related🧫Vascular Contribution to Alzheimer's Disease — Beyond A50%

related🧫Viral Infections and Alzheimer's Disease — causal mecha50%

related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas50%

related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia50%

related🧫Mixed Pathology Effects on Parkinson's Disease Progress50%

related🧫Normal Aging to Alzheimer's Disease Transition Trigger 50%

related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

related🧫Microglial TREM2 Agonist In Vivo Efficacy50%

related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 50%

related🧫Sleep Disruption and Alzheimer's Disease — mechanism an50%

related🧫Proposed experiment from debate on Synaptic pruning by micro50%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti50%

related🧫Gap Junction Dysfunction Validation in Parkinson's Dise50%

related🧫Experiment: Autoimmune Hypothesis Testing in AD50%

mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%

related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis50%

related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation50%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%

related🧫Experiment Validation: In vitro ThT Assay50%

related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M50%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD50%

related🧫Blood-Based Biomarker Panel for Early AD Detection50%

related🧫tACS Connectivity Trial in Early Alzheimer's50%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 50%

related🧫Traumatic Brain Injury and Alzheimer's Disease Relation50%

related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

related🧫Anti-Tau Immunotherapy Dosing Optimization50%

related🧫Neural Stem Cell Therapy for Alzheimer's Disease50%

related🧫Tau ASO Therapy50%

related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease50%

mentions🧫Adoptive transfer of TCRAβ-Tregs in AD mouse model44%

mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease44%

mentions🧫Creation and validation of 3xAD-ChAT-Cre mouse model44%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%

related🔬What are the mechanisms underlying selective vulnerability o38%

related🔬What are the mechanisms underlying rna binding protein dysre38%

related🔬What are the mechanisms underlying mechanistic role of apoe 38%

related🔬Investigate how lipid raft composition (cholesterol metaboli38%

related🔬What are the mechanisms underlying apoe4 structural biology 38%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa38%

related🔬What are the mechanisms underlying blood-brain barrier trans38%

related🔬How does metabolic reprogramming (glucose metabolism shifts,38%

related🔬What are the mechanisms underlying sleep disruption as cause38%

related🔬What are the mechanisms underlying astrocyte reactivity subt38%

related🔬What are the mechanisms underlying digital biomarkers and ai38%

related🔬Analyze circuit-level changes in neurodegeneration using All38%

related🔬What are the mechanisms underlying mitochondrial transfer be38%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp38%

related🔬What are the mechanisms underlying what are the mechanisms b38%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di38%

related🔬What are the mechanisms underlying synaptic pruning by micro38%

related🔬Epigenetic reprogramming in aging neurons38%

related🔬What are the mechanisms underlying neuroinflammation resolut38%

related🔬What are the mechanisms underlying perivascular spaces and g38%

In Alzheimer's disease, biomarker events occur in a specific temporal sequence: amyloid-β abnormalit

💬 Discussion